-
-
-
-
-
-
-
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
-
-
-
-
-
-
-
Centogene N.V. (CNTG) Reports Q3 Revenues of EUR 30.2M, EPS of EUR (0.96)
-
-
-
-
-
-
-
CENTOGENE to Announce Second Quarter 2021 Financial Results on September 7, 2021
-
-
-
-
-
-
-
CENTOGENE Reports Record Fourth Quarter and Full Year 2020 Financial Results
-
-
-
-
-
-
-
CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson’s Disease Study
-
-
-
-
-
-
-
CENTOGENE and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)
-
-
-
-
-
-
-
Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

